Abstract:Renal function and continence of urine are critically dependent on the proper function of the urinary bladder, which stores urine at low pressure and expels it with a precisely orchestrated contraction. A number of congenital and acquired urological anomalies including posterior urethral valves, benign prostatic hyperplasia, and neurogenic bladder secondary to spina bifida/spinal cord injury can result in pathologic tissue remodeling leading to impaired compliance and reduced capacity(1). Functional or anatomical obstruction of the urinary tract is frequently associated with these conditions, and can lead to urinary incontinence and kidney damage from increased storage and voiding pressures(2). Surgical implantation of gastrointestinal segments to expand organ capacity and reduce intravesical pressures represents the primary surgical treatment option for these disorders when medical management fails(3). However, this approach is hampered by the limitation of available donor tissue, and is associated with significant complications including chronic urinary tract infection, metabolic perturbation, urinary stone formation, and secondary malignancy(4,5). Current research in bladder tissue engineering is heavily focused on identifying biomaterial configurations which can support regeneration of tissues at defect sites. Conventional 3-D scaffolds derived from natural and synthetic polymers such as small intestinal submucosa and poly-glycolic acid have shown some short-term success in supporting urothelial and smooth muscle regeneration as well as facilitating increased organ storage capacity in both animal models and in the clinic(6,7). However, deficiencies in scaffold mechanical integrity and biocompatibility often result in deleterious fibrosis(8), graft contracture(9), and calcification(10), thus increasing the risk of implant failure and need for secondary surgical procedures. In addition, restoration of normal voiding characteristics utilizing standard biomaterial constructs for augmentation cystoplasty has yet to be achieved, and therefore research and development of novel matrices which can fulfill this role is needed. In order to successfully develop and evaluate optimal biomaterials for clinical bladder augmentation, efficacy research must first be performed in standardized animal models using detailed surgical methods and functional outcome assessments. We have previously reported the use of a bladder augmentation model in mice to determine the potential of silk fibroin-based scaffolds to mediate tissue regeneration and functional voiding characteristics.(11,12) Cystometric analyses of this model have shown that variations in structural and mechanical implant properties can influence the resulting urodynamic features of the tissue engineered bladders(11,12). Positive correlations between the degree of matrix-mediated tissue regeneration determined histologically and functional compliance and capacity evaluated by cystometry were demonstrated in this model(11,12). These results therefore suggest that functional evaluations of biomaterial configurations in rodent bladder augmentation systems may be a useful format for assessing scaffold properties and establishing in vivo feasibility prior to large animal studies and clinical deployment. In the current study, we will present various surgical stages of bladder augmentation in both mice and rats using silk scaffolds and demonstrate techniques for awake and anesthetized cystometry.

Time-dependent Bladder Tissue Regeneration Using Bilayer Bladder Acellular Matrix Graft-Silk Fibroin Scaffolds in a Rat Bladder Augmentation Model.

Comparison of morphological and functional restoration between asymmetric bilayer chitosan and bladder acellular matrix graft for bladder augmentation in a rat model

A Study on the Repair of Bladder by Pro-Producing Bladder Acellular Matrix Graft-Silk Fibroin in Rats

Adipose-derived Stem Cells-Seeded Bladder Acellular Matrix Graft-Silk Fibroin Enhances Bladder Reconstruction in a Rat Model

Trilayer Three-Dimensional Hydrogel Composite Scaffold Containing Encapsulated Adipose-Derived Stem Cells Promotes Bladder Reconstruction Via SDF-1α/CXCR4 Pathway.

Coadministration of Platelet-Derived Growth Factor-Bb and Vascular Endothelial Growth Factor with Bladder Acellular Matrix Enhances Smooth Muscle Regeneration and Vascularization for Bladder Augmentation in a Rabbit Model.

The Use of Vascular Endothelial Growth Factor with Silk Fibroin Scaffolds and Bladder Acellular Matrix Grafts to Support Bladder Reconstruction in Rabbit Model

Construction of Tissue-Engineered Bladder Scaffolds with Composite Biomaterials

A Lipid-Nanosphere-Small MyoD Activating RNA-Bladder Acellular Matrix Graft Scaffold [NP(saMyoD)/BAMG] Facilitates Rat Injured Bladder Muscle Repair and Regeneration [NP(saMyoD)/BAMG]

Co-administration of PDGF-BB and VEGF with bladder acellular matrix enhance smooth muscle regeneration and vascularization for bladder augmentation in a rabbit model

Bladder muscle regeneration enhanced by sustainable delivery of heparin from bilayer scaffolds carrying stem cells in a rat bladder partial cystectomy model

The enhanced angiogenesis effect of VEGF-silk fibroin nanospheres-BAMG scaffold composited with adipose derived stem cells in a rabbit model

Evaluation of biomaterials for bladder augmentation using cystometric analyses in various rodent models

Biomimetic Multilayer Scaffolds with Prolonged Retention of Stem Cells-Recruiting and Angiogenic Peptides for Promoting Bladder Regeneration

Electrostimulation-Based Decellularized Matrix Bladder Patch Promotes Bladder Repair in Rats

Extracellular Matrix Sheet Modified with VEGF-loaded Nanoparticles for Bladder Regeneration

Bladder Tissue Engineering with Acellular Scaffold

Tissue Performance of Bladder Following Stretched Electrospun Silk Fibroin Matrix and Bladder Acellular Matrix Implantation in a Rabbit Model

Prevascularized Bladder Acellular Matrix Hydrogel/silk Fibroin Composite Scaffolds Promote the Regeneration of Urethra in a Rabbit Model

Construction of Tissue-Engineered Bladders Using an Artificial Acellular Nanocomposite Scaffold Loaded with Stromal Vascular Fraction Secretome.

Bladder Acellular Matrix and Its Application in Bladder Augmentation